R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 484.5 Million USD | 34.1% |
| 2022 | 361.3 Million USD | 15.88% |
| 2021 | 311.8 Million USD | 24.87% |
| 2020 | 249.7 Million USD | 25.92% |
| 2019 | 198.3 Million USD | 102.55% |
| 2018 | 97.9 Million USD | 192.24% |
| 2017 | 33.5 Million USD | -91.47% |
| 2016 | 392.86 Million USD | 859.33% |
| 2015 | -51.73 Million USD | -284.8% |
| 2014 | 27.99 Million USD | -91.2% |
| 2013 | 318.01 Million USD | 373.18% |
| 2012 | -116.41 Million USD | -159.45% |
| 2011 | 195.82 Million USD | 52.97% |
| 2010 | 128.01 Million USD | 28.69% |
| 2009 | 99.48 Million USD | 57.26% |
| 2008 | 63.25 Million USD | 46.94% |
| 2007 | 43.04 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 111.3 Million USD | -8.02% |
| 2024 Q1 | 106.3 Million USD | -20.37% |
| 2024 Q2 | 121 Million USD | 13.83% |
| 2023 Q4 | 133.5 Million USD | 6.54% |
| 2023 Q1 | 110.9 Million USD | 13.86% |
| 2023 Q3 | 125.3 Million USD | 9.15% |
| 2023 Q2 | 114.8 Million USD | 3.52% |
| 2023 FY | 484.5 Million USD | 34.1% |
| 2022 Q3 | 92.9 Million USD | 13.57% |
| 2022 FY | 361.3 Million USD | 15.88% |
| 2022 Q4 | 97.4 Million USD | 4.84% |
| 2022 Q1 | 89.2 Million USD | -5.41% |
| 2022 Q2 | 81.8 Million USD | -8.3% |
| 2021 Q1 | 75.4 Million USD | 16.54% |
| 2021 Q2 | 66.4 Million USD | -11.94% |
| 2021 Q3 | 75.7 Million USD | 14.01% |
| 2021 Q4 | 94.3 Million USD | 24.57% |
| 2021 FY | 311.8 Million USD | 24.87% |
| 2020 Q3 | 52 Million USD | -21.69% |
| 2020 FY | 249.7 Million USD | 25.92% |
| 2020 Q1 | 66.6 Million USD | 29.57% |
| 2020 Q2 | 66.4 Million USD | -0.3% |
| 2020 Q4 | 64.7 Million USD | 24.42% |
| 2019 FY | 198.3 Million USD | 102.55% |
| 2019 Q1 | 38.7 Million USD | -3.73% |
| 2019 Q3 | 59.3 Million USD | 21.27% |
| 2019 Q2 | 48.9 Million USD | 26.36% |
| 2019 Q4 | 51.4 Million USD | -13.32% |
| 2018 Q3 | 31.1 Million USD | 72.78% |
| 2018 Q2 | 18 Million USD | 109.3% |
| 2018 FY | 97.9 Million USD | 192.24% |
| 2018 Q1 | 8.6 Million USD | -34.35% |
| 2018 Q4 | 40.2 Million USD | 29.26% |
| 2017 Q3 | 11.4 Million USD | 280.0% |
| 2017 Q1 | 6 Million USD | -86.39% |
| 2017 FY | 33.5 Million USD | -91.47% |
| 2017 Q4 | 13.1 Million USD | 14.91% |
| 2017 Q2 | 3 Million USD | -50.0% |
| 2016 Q3 | 78.15 Million USD | 314.49% |
| 2016 Q4 | 44.07 Million USD | -43.6% |
| 2016 Q1 | 307.06 Million USD | 935.7% |
| 2016 FY | 392.86 Million USD | 859.33% |
| 2016 Q2 | -36.44 Million USD | -111.87% |
| 2015 Q1 | -31.22 Million USD | -976.37% |
| 2015 Q4 | 29.64 Million USD | 200.56% |
| 2015 Q3 | -29.48 Million USD | -42.59% |
| 2015 Q2 | -20.67 Million USD | 33.78% |
| 2015 FY | -51.73 Million USD | -284.8% |
| 2014 Q4 | 3.56 Million USD | -92.15% |
| 2014 Q3 | 45.37 Million USD | 311.53% |
| 2014 Q2 | 11.02 Million USD | 134.49% |
| 2014 Q1 | -31.96 Million USD | -175.91% |
| 2014 FY | 27.99 Million USD | -91.2% |
| 2013 Q1 | -19.37 Million USD | 92.33% |
| 2013 FY | 318.01 Million USD | 373.18% |
| 2013 Q3 | -29.2 Million USD | -109.0% |
| 2013 Q4 | 42.11 Million USD | 244.21% |
| 2013 Q2 | 324.48 Million USD | 1774.66% |
| 2012 Q2 | 45.31 Million USD | 1.35% |
| 2012 Q3 | 46.16 Million USD | 1.88% |
| 2012 Q1 | 44.7 Million USD | -31.85% |
| 2012 Q4 | -252.59 Million USD | -647.18% |
| 2012 FY | -116.41 Million USD | -159.45% |
| 2011 Q3 | 48.99 Million USD | 4.12% |
| 2011 Q4 | 65.6 Million USD | 33.9% |
| 2011 Q1 | 34.17 Million USD | -10.84% |
| 2011 FY | 195.82 Million USD | 52.97% |
| 2011 Q2 | 47.05 Million USD | 37.7% |
| 2010 FY | 128.01 Million USD | 28.69% |
| 2010 Q2 | 33.89 Million USD | 43.31% |
| 2010 Q4 | 38.32 Million USD | 19.21% |
| 2010 Q3 | 32.15 Million USD | -5.13% |
| 2010 Q1 | 23.64 Million USD | -16.65% |
| 2009 FY | 99.48 Million USD | 57.26% |
| 2009 Q2 | 22.71 Million USD | 14.95% |
| 2009 Q3 | 28.62 Million USD | 26.01% |
| 2009 Q4 | 28.37 Million USD | -0.89% |
| 2009 Q1 | 19.76 Million USD | 11.37% |
| 2008 Q3 | 18.33 Million USD | 0.0% |
| 2008 Q4 | 17.74 Million USD | -3.19% |
| 2008 FY | 63.25 Million USD | 46.94% |
| 2007 FY | 43.04 Million USD | 0.0% |
| 2000 Q4 | 532.79 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 499.7 Million USD | 3.042% |
| GE HealthCare Technologies Inc. | 7.92 Billion USD | 93.884% |
| Sharecare, Inc. | 129.49 Million USD | -274.134% |
| Progyny, Inc. | 238.79 Million USD | -102.89% |
| Aclarion, Inc. | -324.00 USD | 149537137.037% |
| CareMax, Inc. | 13.9 Million USD | -3385.361% |
| Simulations Plus, Inc. | 43.15 Million USD | -1022.801% |
| CareCloud, Inc. | 46.24 Million USD | -947.749% |
| Forian Inc. | 15 Million USD | -3129.075% |
| Bullfrog AI Holdings, Inc. Warrants | 59.8 Thousand USD | -810100.669% |
| Bullfrog AI Holdings, Inc. Common Stock | 59.8 Thousand USD | -810100.669% |
| Minerva Surgical, Inc. | 27.24 Million USD | -1678.504% |
| Omnicell, Inc. | 499.92 Million USD | 3.086% |
| Definitive Healthcare Corp. | 203.93 Million USD | -137.578% |
| Zhongchao Inc. | 8.51 Million USD | -5591.836% |
| Accolade, Inc. | 192.06 Million USD | -152.265% |
| Streamline Health Solutions, Inc. | 11.54 Million USD | -4097.349% |
| Ontrak, Inc. | 8.8 Million USD | -5405.682% |
| SOPHiA GENETICS SA | 42.91 Million USD | -1029.028% |
| Spok Holdings, Inc. | 112.2 Million USD | -331.791% |
| Privia Health Group, Inc. | 161.5 Million USD | -199.998% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -57436.443% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 60.62 Million USD | -699.215% |
| TruBridge, Inc. | 163.56 Million USD | -196.209% |
| Nutex Health, Inc. | 34.77 Million USD | -1293.275% |
| Renalytix Plc | 156 Thousand USD | -310476.923% |
| Sharecare, Inc. | 129.49 Million USD | -274.134% |
| Health Catalyst, Inc. | 131.83 Million USD | -267.51% |
| 10x Genomics, Inc. | 409.31 Million USD | -18.369% |
| GoodRx Holdings, Inc. | 683.34 Million USD | 29.098% |
| SCWorx Corp. | 1.26 Million USD | -38077.322% |
| Schrödinger, Inc. | 140.69 Million USD | -244.369% |
| HealthEquity, Inc. | 622.63 Million USD | 22.186% |
| HealthStream, Inc. | 184.04 Million USD | -163.255% |
| MSP Recovery, Inc. | 5.56 Million USD | -8614.029% |
| Augmedix, Inc. | 21.52 Million USD | -2150.767% |
| BrightSpring Health Services, Inc. Common Stock | 1.43 Billion USD | 66.209% |
| Ontrak, Inc. | 8.8 Million USD | -5405.682% |
| SHL Telemedicine Ltd. | 25.26 Million USD | -1817.976% |
| CareCloud, Inc. | 46.24 Million USD | -947.749% |
| Premier, Inc. | 840.73 Million USD | 42.372% |
| Certara, Inc. | 213.31 Million USD | -127.129% |
| GeneDx Holdings Corp. | 60.62 Million USD | -699.215% |
| OneMedNet Corporation | -127.9 Thousand USD | 378911.572% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.43 Billion USD | 66.209% |
| EUDA Health Holdings Limited | 842.07 Thousand USD | -57436.443% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 46.24 Million USD | -947.749% |
| Mangoceuticals, Inc. | 431.5 Thousand USD | -112182.474% |
| CareMax, Inc. | 13.9 Million USD | -3385.361% |
| Healthcare Triangle, Inc. | 6.77 Million USD | -7049.181% |
| National Research Corporation | 86.66 Million USD | -459.043% |
| Aclarion, Inc. | -324.00 USD | 149537137.037% |
| OptimizeRx Corporation | 42.89 Million USD | -1029.373% |